David R. Spriggs
Harvard University(US)Massachusetts General Hospital(US)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Monoclonal and Polyclonal Antibodies Research, Endometrial and Cervical Cancer Treatments, Immunotherapy and Immune Responses, Statistical Methods in Clinical Trials
Most-Cited Works
- → Detection of Circulating Tumor Necrosis Factor after Endotoxin Administration(1988)1,707 cited
- → Gemcitabine and Docetaxel in Patients With Unresectable Leiomyosarcoma: Results of a Phase II Trial(2002)685 cited
- → Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation.(1989)466 cited
- A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies.(2002)
- → IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumors in vivo(2015)409 cited
- → Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment(2017)389 cited
- → Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings